
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
NBCC (India) won three government projects worth ₹132.28 crore in Assam and Odisha, but its shares slipped 0.78% in early BSE trade.
PepsiCo India’s Rs 1,266-crore Ujjain flavour plant, part of a Rs 5,700-crore India commitment, is drawing investor attention ahead of planned 2026 operations.
Most active NSE and BSE shares by volume on 10 Jul 2026, with key triggers behind heavy trading in telecom, jewellery and select small caps.
Top traded-by-value stocks on NSE and BSE on 10 Jul 2026, with key catalysts behind major moves across large, mid and small caps.
Nifty and Sensex ended sharply lower as crude oil surged on Middle East tensions. Here are the top losing large, mid and small caps and the key triggers behind the fall.
Top gainers on NSE and BSE on 10 Jul 2026, with key catalysts, volume action, and sector cues. IT-led strength stood out despite weak market breadth.
Lux Industries’ board cleared an in-principle demerger, refreshed brand licensing with BHML and promoter entities, while the stock saw sharp moves amid investor interest.
IC Electricals' NSE SME IPO drew bids worth ₹13,432 crore and about 420x subscription, with grey market premium around 40–45% ahead of July 10 listing.
SBI Funds Management’s offer-for-sale IPO opens July 14 with a Rs 545–574 price band, targeting up to Rs 1.17 trillion valuation and no fresh issue.
L&T Finance reported Q1 FY26 PAT of about ₹701 crore and total income of ₹4,259.6 crore, with improved stage-3 ratios and higher retail disbursements.
Stock market today: Nifty and Sensex steadied after the mid-week shock as crude cooled and earnings cues improved. Here’s what moved markets and what to track next.
Social media chatter on Ujjivan SFB is focused on near-term support and resistance, while brokerage notes keep a buy bias and targets ranging from the high-50s to 80.
Lenskart Solutions shares traded close to a 52-week high as CLSA and other brokerages turned positive, following strong FY26 quarterly revenue growth and target price hikes.
OneSource Specialty Pharma’s Q3 FY26 loss and Canada approval delays hit the stock, but management reaffirmed FY28 targets as Q4 revenue recovered after India semaglutide launch.
Advait Energy Transitions rose over 2% after its subsidiary signed a 12-year battery energy storage purchase agreement with GUVNL for a 150 MW/300 MWh project in Gujarat.
Ion Exchange (India) share price remains well below its 52-week high as investors track recent returns, Q4 profit decline, and FY2026 margin pressure despite revenue growth signals.